Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection

被引:41
作者
Rouan, MC
Marfil, F
Mangoni, P
Séchaud, R
Humbert, H
Maurer, G
机构
[1] Novartis Pharma SA, Drug Metab & Pharmacokinet, F-92500 Rueil Malmaison, France
[2] Novartis Pharma AG, Clin Pharmacol, CH-4002 Basel, Switzerland
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 755卷 / 1-2期
关键词
ICL670; iron chelators;
D O I
10.1016/S0378-4347(01)00079-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
ICL670 is a representative of a new class of orally active tridentate selective iron chelators. Two molecules of ICL670 are required to form a complete hexacoordinate chelate Fe-[ICL670](2) with one ferric iron. A simple and rapid HPLC-UV method for the separate determination of ICL670 and Fe-[ICL670](2) in the plasma of iron-overloaded patients is described. Plasma samples were prepared as rapidly as possible, the tubes being kept at 4 degreesC. Plasma proteins were precipitated with methanol. The supernatant was diluted with water and placed on the refrigerated sample rack of an autosampler before injection. The chromatographic separations were achieved on an Alltima C-18 column using 0.05 M Na2HPO4 and 0.01 M tetrabutylammonium hydrogen sulfate-acetonitrile-methanol (41:9:50, v/v/v) as mobile phase. The analytes were detected at 295 nm. Calibration and quality control samples were prepared in normal human plasma. The mean accuracy (n=6) over the entire investigated concentration range 0.25-20 mug/ml ranged from 91 to 109% with a coefficient of variation (C.V.) from 4 to 8% for ICL670, and from 95 to 105% with a C.V. from 2 to 20% for the iron complex. The dissociation of the complex during analysis was shown to be marginal. The iron removal from plasma of iron-overloaded patients by free ICL670 during analysis was low. The in vitro iron transfer from the iron pools of iron-overloaded plasma onto ICL670 was shown to be a slow process. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:203 / 213
页数:11
相关论文
共 16 条
[1]   RESULTS OF LONG-TERM DEFERIPRONE (L1) THERAPY - A REPORT BY THE INTERNATIONAL STUDY-GROUP ON ORAL IRON CHELATORS [J].
ALREFAIE, FN ;
HERSHKO, C ;
HOFFBRAND, AV ;
KOSARYAN, M ;
OLIVIERI, NF ;
TONDURY, P ;
WONKE, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (01) :224-229
[2]   CHANGES IN TRANSFERRIN SATURATION AFTER TREATMENT WITH THE ORAL IRON CHELATOR DEFERIPRONE IN PATIENTS WITH IRON OVERLOAD [J].
ALREFAIE, FN ;
DESILVA, CE ;
WONKE, B ;
HOFFBRAND, AV .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (02) :110-114
[3]   EVALUATION OF THE RELATIVE EFFICACY OF VARIOUS TECHNIQUES FOR DEPROTEINIZING PLASMA SAMPLES PRIOR TO HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS [J].
BLANCHARD, J .
JOURNAL OF CHROMATOGRAPHY, 1981, 226 (02) :455-460
[4]  
BORGNAPIGNATTI C, 1991, HAEMATOLOGICA, V76, P409
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF DEFEROXAMINE AND FERRIOXAMINE - INTERFERENCE BY IRON PRESENT IN THE CHROMATOGRAPHIC SYSTEM [J].
CRAMER, SM ;
NATHANAEL, B ;
HORVATH, C .
JOURNAL OF CHROMATOGRAPHY, 1984, 295 (02) :405-411
[6]   CHROMATOGRAPHY OF 3-HYDROXYPYRIDIN-4-ONES - NOVEL ORALLY ACTIVE IRON CHELATORS [J].
EPEMOLU, RO ;
SINGH, S ;
HIDER, RC ;
DAMANI, LA .
JOURNAL OF CHROMATOGRAPHY, 1990, 519 (01) :171-178
[7]  
GODDARD JG, 1990, CLIN CHEM, V36, P5
[8]  
GROOTVELD M, 1989, J BIOL CHEM, V264, P4417
[9]   NONSPECIFIC SERUM IRON IN THALASSEMIA - ABNORMAL SERUM IRON FRACTION OF POTENTIAL TOXICITY [J].
HERSHKO, C ;
GRAHAM, G ;
BATES, GW ;
RACHMILEWITZ, EA .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (02) :255-263
[10]   Quantification of desferrioxamine, ferrioxamine and aluminoxamine by post-column derivatization high-performance liquid chromatography - Non-linear calibration resulting from second-order reaction kinetics [J].
Kraemer, HJ ;
Breithaupt, H .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 710 (1-2) :191-204